Osteosarcoma
2022 · Nature Reviews Disease Primers · 541 citations
https://doi.org/10.1038/s41572-022-00409-y
H
Hannah C. Beird
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
2.0K
Citations
19
h-index
26
i10-index
Hannah C. Beird is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Ovarian cancer diagnosis and treatment & Cancer-related molecular mechanisms research. The author has an h-index of 19, co-authored 88 publications.
ORCID: 0000-0002-5078-534XPapers by this author
worksSingle cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
2021 · Nature Communications · 128 citations
https://doi.org/10.1038/s41467-021-26282-z
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
2025 · Nature · 49 citations
https://doi.org/10.1038/s41586-025-09655-y
Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)
2019 · Blood Cancer Journal · 42 citations
https://doi.org/10.1038/s41408-019-0262-0
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
2022 · Nature Communications · 29 citations
https://doi.org/10.1038/s41467-022-30710-z
Multi-site desmoplastic small round cell tumors are genetically related and immune-cold
2022 · npj Precision Oncology · 25 citations
https://doi.org/10.1038/s41698-022-00257-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat